Marvel Biosciences Corp.
MRVL.V
TSX
| 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 41.10K | 59.80K | 250.30K | 158.40K | 431.80K |
| Total Receivables | 92.00K | 89.60K | 83.90K | 78.40K | 75.50K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 18.30K | 14.70K | 21.40K | 15.90K | 24.30K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 151.40K | 164.10K | 355.70K | 252.70K | 531.60K |
|
|
|||||
| Total Current Assets | 151.40K | 164.10K | 355.70K | 252.70K | 531.60K |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 151.40K | 164.10K | 355.70K | 252.70K | 531.60K |
|
|
|||||
| Total Accounts Payable | 1.21M | 964.60K | 975.80K | 1.02M | 1.12M |
| Total Accrued Expenses | 214.50K | 184.40K | 187.70K | 144.70K | 121.00K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 1.42M | 1.15M | 1.16M | 1.17M | 1.25M |
|
|
|||||
| Total Current Liabilities | 1.42M | 1.15M | 1.16M | 1.17M | 1.25M |
| Long-Term Debt | 1.18M | 1.23M | 1.24M | 1.09M | 1.12M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 2.60M | 2.38M | 2.40M | 2.26M | 2.37M |
|
|
|||||
| Common Stock & APIC | 5.24M | 5.44M | 5.49M | 5.35M | 5.49M |
| Retained Earnings | -7.92M | -7.88M | -7.75M | -7.35M | -7.33M |
| Treasury Stock & Other | 230.60K | 226.80K | 213.30K | -- | -- |
| Total Common Equity | -2.45M | -2.21M | -2.05M | -2.01M | -1.83M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -2.45M | -2.21M | -2.05M | -2.01M | -1.83M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -2.45M | -2.21M | -2.05M | -2.01M | -1.83M |
|
|
|||||